VANCOUVER, BC, October 8, 2021 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has granted a total of 955,000 stock options to employees and consultants. The stock options granted are exercisable to purchase a common share of the Company at a price of CAD$ 0.34 per share for a term of 10 years. 615,000 stock options granted will vest quarterly, and 300,000 will vest monthly over 3 years. 20,000 stock options will vest quarterly over 2 years and the remaining 20,000 stock options granted will vest monthly over 6 months.
Additionally, the Company has issued a total of 50,000 warrants to a consultant as part of the terms of his service agreement. Each warrant is immediately exercisable to purchase one share of common stock at an exercise price of CAD$ 0.34 and will expire 2 years from the date of issuance.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets. Visit:www.bioharvest.com.